The Diagnostics & Lab Testing Business Brief — Sunday, November 15, 2026
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
Summary
The Diagnostics & Lab Testing Business Brief — Sunday, November 15, 2026
- VedaBio presents proof-of-concept data at AMP 2026 showing under-10-minute sample-to-answer molecular detection with its target amplification-free CRISPR technology, using a five-result respiratory panel prototype with automated nucleic acid extraction. (Business Wire)
- NeuroKaire showcases its BrightKaire platform at HLTH 2026: from a standard blood draw, patient-specific functional neurons are generated and antidepressants ranked, with company-reported AUC of 0.81 and 84% positive predictive value. (GlobeNewswire)
- Feminai, developer of a wearable sensor patch using AI to monitor breast tissue changes for at-home breast cancer screening, captured the $350,000 MedTech Innovator Early-Stage Grand Prize, as ASPS announced its Plastic Surgery Track startups won a combined $355,000. (GlobeNewswire)
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.